Maglangit, Keith Thaddeus B.
HRN: 27-76-60 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/08/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/08/2025
09/15/2025
IVTT
500MG
Q8
RUPTURED APPENDICITIS
Checking Initial Appropriateness
09/08/2025
CEFTRIAXONE 1G (VIAL)
09/08/2025
09/15/2025
IVTT
1g
Q12
Ruptured Appendicitis
Checking Initial Appropriateness
09/10/2025
MUPIROCIN 2%, 15G (TUBE)
09/10/2025
09/17/2025
TOPICAL
Apply To Postop Site
BID
S/P Appendectomy
Checking Initial Appropriateness